NPCE - NASDAQ

NeuroPace, Inc.

NPCE·NASDAQ

$15.88

-2.5%

HealthcareMedical - Devices

NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. The company was incorporated in 1997 and is headquartered in Mountain View, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$541.41M

EPS-0.6600

P/E Ratio-24.06

Earnings Date08/11/2026

npce

Total Non-Current Liabilities

Last Annual Value

68.72M

3-Year CAGR

5-Year CAGR

-19%

10-Year CAGR

-1%

Adjust for Inflation

NeuroPace, Inc. Competitors Analysis of Total Non-Current Liabilities

NPCE · NASDAQ

Company	Total Non-Current Liabilities	CAGR 3Y	CAGR 5Y	CAGR 10Y
NeuroPace, Inc. NASDAQ:NPCE	68.72M	-1.0%	6.2%	N/A
Delcath Systems, Inc. NASDAQ:DCTH	1.46M	-38.8%	-37.4%	8.7%
Senseonics Holdings, Inc. NASDAQ:SENS	40.88M	-21.7%	-35.5%	10.2%
CVRx, Inc. NASDAQ:CVRX	52.15M	18.4%	138.1%	N/A
Aldeyra Therapeutics, Inc. NASDAQ:ALDX	0.00	N/A	N/A	N/A
RxSight, Inc. NASDAQ:RXST	9.88M	97.4%	-25.6%	N/A
Genelux Corporation NASDAQ:GNLX	1.26M	-12.3%	-41.7%	N/A
908 Devices Inc. NASDAQ:MASS	12.31M	-6.3%	-17.1%	N/A
Cerus Corporation NASDAQ:CERS	56.09M	-9.9%	-5.2%	11.6%
Sight Sciences, Inc. NASDAQ:SGHT	40.33M	5.7%	3.1%	N/A

NeuroPace, Inc. Fair Value Envelope

NPCE · NASDAQ

Our analysis suggests that NPCE has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $15.88, this represents a potential HIDDEN relative to our calculated worth for NeuroPace, Inc..

HIDDEN

Intrinsic Value

Current Price: $15.88

Related Guides

Blog Categories

Continue your NPCE research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.